Effects of XW003 Versus Liraglutide on Body Weight of Adult Participants With Obesity
Condition:   Obesity Interventions:   Drug: XW003;   Drug: Saxenda Sponsors:   Sciwind Biosciences APAC CO Pty. Ltd.;   Hangzhou Sciwind Biosciences Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 8, 2021 Category: Research Source Type: clinical trials